- Home
- IVA vs AMRN Comparison
IVA vs AMRN Comparison
Compare IVA & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVA
- AMRN
- Stock Information
- Founded
- IVA 2011
- AMRN 1989
- Country
- IVA France
- AMRN Ireland
- Employees
- IVA N/A
- AMRN N/A
- Industry
- IVA Biotechnology: Pharmaceutical Preparations
- AMRN Biotechnology: Pharmaceutical Preparations
- Sector
- IVA Health Care
- AMRN Health Care
- Exchange
- IVA Nasdaq
- AMRN Nasdaq
- Market Cap
- IVA 162.8M
- AMRN 189.2M
- IPO Year
- IVA 2020
- AMRN 1993
- Fundamental
- Price
- IVA $3.22
- AMRN $0.39
- Analyst Decision
- IVA Strong Buy
- AMRN Buy
- Analyst Count
- IVA 4
- AMRN 1
- Target Price
- IVA $13.25
- AMRN N/A
- AVG Volume (30 Days)
- IVA 8.7K
- AMRN 2.2M
- Earning Date
- IVA 03-26-2025
- AMRN 04-30-2025
- Dividend Yield
- IVA N/A
- AMRN N/A
- EPS Growth
- IVA N/A
- AMRN N/A
- EPS
- IVA N/A
- AMRN N/A
- Revenue
- IVA $15,243,814.00
- AMRN $228,614,000.00
- Revenue This Year
- IVA $18.05
- AMRN N/A
- Revenue Next Year
- IVA $46.74
- AMRN $1.47
- P/E Ratio
- IVA N/A
- AMRN N/A
- Revenue Growth
- IVA N/A
- AMRN N/A
- 52 Week Low
- IVA $1.53
- AMRN $0.35
- 52 Week High
- IVA $3.98
- AMRN $1.11
- Technical
- Relative Strength Index (RSI)
- IVA 50.87
- AMRN 34.65
- Support Level
- IVA $2.88
- AMRN $0.42
- Resistance Level
- IVA $3.10
- AMRN $0.46
- Average True Range (ATR)
- IVA 0.22
- AMRN 0.03
- MACD
- IVA -0.01
- AMRN 0.00
- Stochastic Oscillator
- IVA 30.37
- AMRN 12.00
About IVA Inventiva S.A. American Depository Shares
Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.